Breast cancer risk hazy in hormone study

Lebanese researchers studied data from the Women’s Health Initiative (WHI) clinical trial of oestrogen and progestin therapy and found its effect on breast cancer risk was strongest in women whose pre-treatment levels of total oestradiol, bioavailable oestradiol, and oestrone were in the lowest quartiles.

# Tags